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Summary Acute acalculous cholecystitis (AAC) in association with acute Epstein—Barr virus
(EBV) infection has rarely been described in childhood. In the literature, there are only four
reported pediatric cases of AAC associated with isolated primary EBV infection. We present two
cases (one new, one retrospectively reviewed) of children with Gilbert’s syndrome (GS) who
presented with AAC during the course of primary EBV infection. Antibiotics were not used and AAC
subsided gradually as the infection regressed. The co-occurrence of GS might have played a
contributory role in the pathogenesis of AAC during acute EBV infection.
# 2008 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.Introduction
The vast majority of people with Epstein—Barr virus (EBV)
infection, especially children, recover uneventfully,
although a wide range of complications of acute EBV infec-
tion have been reported.1 Hepatitis with mild transient
elevations in serum aminotransferases is often reported,
and mild jaundice develops in approximately 5% of cases,* Corresponding author. 30 Miltiadou Street, Glyfada, 16675,
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Isolated gall bladder wall thickening or hydrops of gall blad-
der have been described in patients with EBV infectious
mononucleosis.2,3 However, acute acalculous cholecystitis
(AAC) in association with acute EBV infection has rarely been
described in childhood. In the literature, there are only four
pediatric cases (two children and two adolescents) of AAC
associated with isolated primary EBV infection, all published
within the past two years.4—7
Gilbert’s syndrome (GS) is a benign condition character-
ized by mild unconjugated hyperbilirubinemia in the absence
of liver disease or overt hemolysis; it occurs in 11—16% ofPublished by Elsevier Ltd. All rights reserved.
Figure 1 Ultrasonographic image of the gall bladder showing a
striated and thickened wall (4.2 mm).
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homozygous for an additional TA in the TATAA box of the
UGT1A1 gene promoter, which encodes a uridine diphosphate
glucuronosyltransferase that catalyzes bilirubin glucuronida-
tion. The presence of this mutation, recently named
UGT1A1*28, results in a decrease in hepatic bilirubin glucur-
onidation activity by 80% in homozygous subjects. GS is a
contributory factor in prolonged neonatal jaundice in
breastfed infants, it might precipitate jaundice when coin-
herited with other disorders of heme metabolism, and might
lead to pharmacological variation in drug glucuronidation
and unexpected toxicity from therapeutic agents.8
We present two cases (one new, one already reported4 but
retrospectively reviewed) of children with GS who presented
with AAC during the course of primary EBV infection. We
presume that GSmight have played a role in the pathogenesis
of AAC during acute EBV infection.
Case report 1
A previously healthy, five-year-old male was admitted to our
hospital with a seven-day history of fever, sore throat and
malaise. Physical examination showed a well-developed
white male who appeared fatigued, but alert and responsive.
The sclerae were icteric and mucous membranes were dry.
Exudative tonsillopharyngitis and bilateral cervical adeno-
pathy were noticed, with the largest nodes measuring 2 cm in
diameter. Abdominal examination revealed a nondistended
abdomen with normally active bowel sounds. The liver was
palpable 3 cm under the costal margin, whereas the spleen
edge was palpable 2 cm below the left costal margin. The
remaining physical findings were normal.
Laboratory investigations on admission revealed a white
blood cell count of 23.3  109/l (10% atypical lymphocytes);
hemoglobin 10.4 g/dl; platelet count 258  109/l; alanine
aminotransferase 257 U/L (5—45 U/L); aspartate aminotrans-
ferase 207 U/L (5—45 U/L); alkaline phosphatase 919 U/L
(38—148 U/L); g-glutamyltransferase 333 U/L (7—32 U/L);
total serum bilirubin 1.8 mg/dl with a direct fraction of
0.9 mg/dl; erythrocyte sedimentation rate 40 mm/hour;
and C-reactive protein 13 mg/l (0—5 mg/l). Results of direct
and indirect Coomb’s test were negative, and glucose-6-
phosphate dehydrogenase activity was normal. Coagulation
studies were within the normal range.
Infectious mononucleosis was suspected and diagnosed by
serological and PCR tests. IgM and IgG antibodies against
Epstein—Barr viral capsid antigen (VCA) were both positive,
IgG antibodies against the early Epstein-Barr viral antigen
(EA) were also positive, whereas IgG antibodies for EBV
nuclear antigen (EBNA) were negative. In addition, detection
of EBV-DNA in serum, using real-time PCR, was positive.
Serological studies excluded ongoing infection caused by
other viral agents, such as hepatitis A, B, C viruses, cytome-
galovirus, HIV, adenovirus and enteroviruses.
On the second hospital day, the child complained of
abdominal pain. Tenderness localized over the right upper
quadrant was noted upon physical examination. Ultrasono-
graphic examination of the abdomen showed hepatospleno-
megaly and a striated thickened gall bladder wall measuring
4.2 mm,with no evidence of stones or dilatation of the biliary
tract (Figure 1). In addition, there was tenderness over the
gall bladder, the so-called positive sonographic Murphy’ssign. AAC was diagnosed and follow-up ultrasonographic
examination of the abdomen was obtained. Further diagnos-
tic work-up, including blood and stool cultures, was negative.
No parasitic or group A streptococci infection was identified,
and serological tests for Brucella species, Salmonella typhi,
Leptospira species, Mycoplasma species, Rickettsia rickettsii
and Coxiella burnetii were negative.
During the seven days of hospitalization, the child
remained in a good general condition, with mild, periodic
right hypochondrial tenderness. AAC regressed gradually. By
the sixth hospital day, the abdominal pain, gall bladder
abnormalities and fever had resolved. The patient was dis-
charged on the seventh day of admission following consider-
able improvement in biochemical results. During a follow up
six months later, the child was in a very good condition
without recurrence. EBNA IgG antibodies became positive,
confirming the diagnosis of EBV primary infection.
Because of the presence of mild unconjugated hyperbilir-
ubinemia, the boy was examined for GS. The promoter region
[A(TA)nTAA] of the UGT1A1 gene was analyzed using methods
previously described.9 The boy was found to be homozygous
for the mutation UGT1A1*28.
Case report 2
The second case of AAC has already been reported.4 It
described a previously healthy, four-year-old girl with AAC
that occurred in the course of EBV infectious mononucleosis.
Shortly after the finding that the child described in case
report 1 had GS, this child was examined for the presence of
the UGT1A1*28 mutation. Interestingly, she was also found to
be homozygous for this mutation.
Discussion
AAC is an inflammatory process of the gall bladder in the
absence of gallstones. The disease is rare in childhood and
most cases occur during the course of infectious diseases such
as septicemia, salmonellosis, brucellosis or hepatitis A virus.
Other etiologic agents include major cardiac or abdominal
surgery, burns and prolonged parenteral nutrition.10—12 Cri-
teria such as gall bladder wall thickening of over 3 mm,
distention of the gall bladder, striated gall bladder wall,
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cholecystic fluid and sludge have been used for the diagnosis
of AAC. The combination of two ormore of the above criteria,
in the appropriate clinical setting, is considered to be diag-
nostic.11,13 In light of the sporadic presentation of AAC, the
etiologic pattern and clinical spectrum of the disease in
childhood have not been well established.
Recently, four pediatric cases (two children and two
adolescents) of AAC associated with isolated primary EBV
infection have been described.4—7. In all four reports, AAC
subsided during the regression of the EBV infection without
needing surgical intervention. Our new patient presented
with the clinical features of infectious mononucleosis. Ser-
ological tests and a PCR assay confirmed primary EBV infec-
tion. On the second hospital day, our patient developed the
criteria of AAC, that is, a striated and thickened gall bladder
and sonographic Murphy’s sign. Antibiotics were not used and
AAC had an excellent prognosis, subsiding gradually during
the regression of the infectious mononucleosis, as happened
in all previously reported cases. Interestingly, the child was
diagnosed with GS, as was the child with AAC and EBV
infection reported in 2007.4
The exact pathogenesis of AAC remains uncertain. The
main cause is thought to be bile stasis and increased litho-
genicity of bile, resulting in gall bladder inflammation.14
Recently, EBV-induced hepatitis has been recognized as an
important cause of cholestasis.15 Our patient had cholestatic
hepatitis with elevated g-glutamyltransferase and alkaline
phosphatase activities, due to confirmed acute EBV infec-
tion. Therefore, our new case further supports the role of bile
stasis in the pathogenesis of AAC and also suggests a possible
role for EBV-induced cholestasis.
A reduction in hepatic glucuronidase activity has been
observed in patients with GS, resulting in high levels of
unconjugated bilirubin and a 30% increase in bilirubin mono-
glucuronide excreted in the bile. The monoglucuronide is less
water soluble than the normal diglucuronide.16,17 This sup-
ports the idea that GS might contribute in either a synergistic
or an additive pattern to the cholestasis induced by EBV
infection. Thus, the presence of GS in an individual with
cholestasis of infectious origin (EBV infection in our cases)
could play a contributory role in the development of gall
bladder abnormalities. Unfortunately, we could not examine
a third reported child from Greece for the presence of GS.5
Nevertheless, the slightly increased incidence of GS in the
Greek and Italian population (18.6% and 16.9%, respec-
tively),9,18 higher than that observed in the north European
population, might explain that the four out of five children
reported with AAC are from Greece or Italy. However,
because of the small number of childhood cases of AAC
and because GS is a common disorder (11—16% of Cauca-
sians), at this time, we can only presume the contributory
role of GS in the development of AAC in children with EBV
infection.
Recently, Guala et al.,19 who studied a few selected
hospitalized pediatric patients, reported that EBV might
impair liver function mostly in individuals homozygous or
heterozygous for the UGT1A1*28 mutation. They suggested
that a more severe clinical course of EBV infectious mono-
nucleosis could be an expected consequence of this genetic
variation. If liver involvement and subsequent cholestasis
during EBV infection is seenmore often in individuals with GS,then increased incidence of gall bladder abnormalities,
including the full manifestation of AAC, could also be
expected.
We have reported two cases of children with GS who
presented with AAC during the course of primary EBV infec-
tion. The co-occurrence of GS might have played a role in the
pathogenesis of AAC during the acute EBV infection. More
studies are needed to determine whether GS predisposes gall
bladder involvement during primary EBV infection and to
clarify the influence of GS genotype on the nature of EBV
infection.
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